ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 725671 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 725671; 2) Community: the network communities that were significantly associated with the response to NSC 725671; 3) Molecule: the relationships between components within communities and NSC 725671; 4) MDR: the compounds that were significantly associated with the NSC 725671.

NSC Compound Enrichment Correlation
NSC 46401 .alpha.-Sarcin 0.000778243021198122 -0.0083068704
NSC 59220 [[5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3, 4-dihydroxyoxolan-2-yl]methoxy-ydroxyphosphoryl] [3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate, disodium salt 0.000778243021198122 0.51214979
NSC 639174 Camptothecin Derivative 0.000778243021198122 0.42267152
NSC 687305 4-(N-acetyl-N-ethylamino)isoquinoline-1-carboxaldehyde thiosemicarbazone 0.000967118311825465 0.54280717
NSC 697653 Null 0.000967118311825465 0.47203696
NSC 700455 Quinoline-3,3,4,4-tetracarbonitrile, 2-(4-bromophenyl)-1,2,3,4,5,6,7,8-octahydro- 0.00165587325865809 0.29219101
NSC 740 Methotrexate 0.0016558732586581 0.60044072
NSC 758423 Amsacrine (USAN) 0.0016558732586581 0.62669689
NSC 627371 2,1,3-Benzoselanadiazole, nitro-6-(trifluoromethyl)- 0.00180888338647612 0.1498983
NSC 639511 Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(4-methoxy- phenyl)methylene]-, hydrochloride 0.00180888338647612 0.1613518
Total:71  Current:2    [First] [Prev] [Next] [Last]